课题基金 / 基金详情

SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY & ARA C IN GLIOMA

SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY & ARA C IN GLIOMA
SWOG 9149--先注射顺铂，然后输注 12 小时羟基
批准号：
6263752
负责人：
CHRISTY RUSSELL
金额：
$3.56万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6263752
关键词：
cis platinum compound clinical research combination chemotherapy cytosine arabinoside glioma human subject human therapy evaluation hydroxyurea neoplasm /cancer chemotherapy neoplasm /cancer relapse /recurrence

项目摘要

项目成果

CHRISTY RUSSELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phase II study of cisplatin, hydroxyurea and ara-c for patients with primary malignant glimoas. This study will evaluate the 6 month survival rate in patients with glimoas recurrent or refractory to surgery, radiotherapy, and/or nitrosoureas. It'll also evaluate the toxicities of this regime and evaluate the response for this patient population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gemcitabine and Cisplatin in Treatment of Breast Cancer
VX710 & TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL
SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY & ARA C IN GLIOMA
VX710 & TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL
海外基金